{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T20:11:43Z","timestamp":1762459903072,"version":"build-2065373602"},"reference-count":47,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","joms.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Oral and Maxillofacial Surgery"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.joms.2020.08.012","type":"journal-article","created":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T10:27:11Z","timestamp":1597487231000},"page":"2138-2146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Tocilizumab, a Potent Interleukin-6 Receptor Inhibitor, Decreases Bone Resorption and Increases the Rate of Bacterial Infection After Tooth Extraction in Rats"],"prefix":"10.1016","volume":"78","author":[{"given":"Maria","family":"Imaculada de Queiroz Rodrigues","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joyce","family":"Ohana de Lima Martins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo Goberl\u00e2nio de Barros","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ant\u00f4nio Ernando","family":"Carlos Ferreira J\u00fanior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Elisa","family":"Quezado Lima Verde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabr\u00edcio Bit\u00fa","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e1rio Rog\u00e9rio","family":"Lima Mota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Paula","family":"Negreiros Nunes Alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.joms.2020.08.012_bib1","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1016\/j.bbapap.2014.07.008","article-title":"Mutational approaches to improve the biophysical properties of human single-domain antibodies","volume":"1844","author":"Kim","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.joms.2020.08.012_bib2","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2147\/PPA.S46192","article-title":"A review of denosumab for the treatment of osteoporosis","volume":"8","author":"Miyazaki","year":"2014","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.joms.2020.08.012_bib3","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.pain.2013.03.026","article-title":"Inhibition of IL-6 signaling: A novel therapeutic approach to treating spinal cord injury pain","volume":"154","author":"Guptarak","year":"2013","journal-title":"Pain"},{"key":"10.1016\/j.joms.2020.08.012_bib4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.pharmthera.2013.09.004","article-title":"Targeting interleukin-6 in inflammatory autoimmune diseases and cancers","volume":"141","author":"Yao","year":"2014","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.joms.2020.08.012_bib5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1200\/JCO.2012.44.2020","article-title":"Possible role for tocilizumab, an anti-interleukin-6 receptor antibody, in treating cancer cachexia","volume":"31","author":"Ando","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.joms.2020.08.012_bib6","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1158\/1940-6207.CAPR-16-0180","article-title":"Benefits of Multifaceted Chemopreventives in the suppression of the oral squamous cell carcinoma (OSCC) Tumorigenic Phenotype","volume":"10","author":"Mallery","year":"2017","journal-title":"Cancer Prev Res"},{"key":"10.1016\/j.joms.2020.08.012_bib7","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s00296-009-1075-4","article-title":"Tocilizumab, a humanized anti-interleukin-6 receptor antibody, improved anemia in monkey arthritis by suppressing IL-6-induced hepcidin production","volume":"30","author":"Hashizume","year":"2010","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.joms.2020.08.012_bib8","doi-asserted-by":"crossref","first-page":"R141","DOI":"10.1186\/ar4323","article-title":"Comparative evaluation of the effects of treatment with tocilizumab and TNF-\u03b1 inhibitors on serum hepcidin, anemia response and disease activity in rheumatoid arthritis patients","volume":"15","author":"Song","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.joms.2020.08.012_bib9","doi-asserted-by":"crossref","first-page":"105954","DOI":"10.1016\/j.ijantimicag.2020.105954","article-title":"The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality","volume":"15","author":"Zhang","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.joms.2020.08.012_bib10","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/jmv.25801","article-title":"Tocilizumab treatment in COVID-19: A single center experience","volume":"92","author":"Luo","year":"2020","journal-title":"J Med Virol"},{"key":"10.1016\/j.joms.2020.08.012_bib11","doi-asserted-by":"crossref","first-page":"10970","DOI":"10.1073\/pnas.2005615117","article-title":"Effective treatment of severe COVID-19 patients with tocilizumab","volume":"117","author":"Xu","year":"2020","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.joms.2020.08.012_bib12","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1601-0825.2011.01867.x","article-title":"Interleukin-6 in oral diseases: A review","volume":"18","author":"Nibali","year":"2012","journal-title":"Oral Dis"},{"key":"10.1016\/j.joms.2020.08.012_bib13","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00210-010-0596-4","article-title":"Zoledronic acid inhibits RANK expression and migration of osteoclast precursors during osteoclastogenesis","volume":"383","author":"Kimachi","year":"2011","journal-title":"Naunyn-Schmied Arch Pharmacol"},{"key":"10.1016\/j.joms.2020.08.012_bib14","doi-asserted-by":"crossref","first-page":"e0183506","DOI":"10.1371\/journal.pone.0183506","article-title":"Effects of metformin on inflammation, oxidative stress, and bone loss in a rat model of periodontitis","volume":"12","author":"Ara\u00fajo","year":"2017","journal-title":"PLoS one"},{"key":"10.1016\/j.joms.2020.08.012_bib15","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1177\/1535370213520114","article-title":"Infliximab attenuates inflammatory osteolysis in a model of periodontitis in Wistar rats","volume":"239","author":"Gon\u00e7alves","year":"2014","journal-title":"Exp Biol Med"},{"key":"10.1016\/j.joms.2020.08.012_bib16","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ajpath.2017.10.011","article-title":"Distinct effects of IL-6 classic and Trans-signaling in bone fracture healing","volume":"188","author":"Prystaz","year":"2018","journal-title":"The Am J Pathol"},{"key":"10.1016\/j.joms.2020.08.012_bib17","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.archoralbio.2012.07.017","article-title":"Assessing the oral microbiota of healthy and alcohol-treated rats using whole-genome DNA probes from human bacteria","volume":"58","author":"Jabbour","year":"2013","journal-title":"Arch Oral Biol"},{"key":"10.1016\/j.joms.2020.08.012_bib18","doi-asserted-by":"crossref","first-page":"959","DOI":"10.2217\/imt-2016-0020","article-title":"Immunotherapeutic implications of IL-6 blockade for cytokine storm","volume":"8","author":"Tanaka","year":"2016","journal-title":"Immunotherapy"},{"key":"10.1016\/j.joms.2020.08.012_bib19","doi-asserted-by":"crossref","first-page":"e664","DOI":"10.1097\/CCM.0000000000001639","article-title":"Effects of tocilizumab on experimental severe acute Pancreatitis and associated acute lung injury","volume":"44","author":"Chen","year":"2016","journal-title":"Crit Care Med"},{"key":"10.1016\/j.joms.2020.08.012_bib20","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.archoralbio.2015.05.015","article-title":"Effect of different doses of zoledronic acid in establishing of bisphosphonate-related osteonecrosis","volume":"60","author":"Silva","year":"2015","journal-title":"Arch Oral Biol"},{"key":"10.1016\/j.joms.2020.08.012_bib21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.archoralbio.2016.11.009","article-title":"Anti-inflammatory effect of a fatty acid mixture with high \u03c9-9:\u03c9-6 ratio and low \u03c9-6:\u03c9-3 ratio on rats submitted to dental extraction","volume":"74","author":"Melo","year":"2017","journal-title":"Arch Oral Biol"},{"key":"10.1016\/j.joms.2020.08.012_bib22","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/odi.12513","article-title":"Immune cellular profile of bisphosphonate-related osteonecrosis of the jaw","volume":"22","author":"Silva","year":"2016","journal-title":"Oral Dis"},{"key":"10.1016\/j.joms.2020.08.012_bib23","doi-asserted-by":"crossref","first-page":"104680","DOI":"10.1016\/j.archoralbio.2020.104680","article-title":"Influence of infliximab therapy on bone healing post-dental extraction in rats","volume":"112","author":"Ferreira J\u00fanior","year":"2020","journal-title":"Arch Oral Biol"},{"key":"10.1016\/j.joms.2020.08.012_bib24","doi-asserted-by":"crossref","first-page":"16975","DOI":"10.1073\/pnas.1315862110","article-title":"STAT3 activation in response to IL-6 is prolonged by the binding of IL-6 receptor to EGF receptor","volume":"110","author":"Wang","year":"2013","journal-title":"Proc The Natl Acad Of Sci"},{"key":"10.1016\/j.joms.2020.08.012_bib25","doi-asserted-by":"crossref","first-page":"4468","DOI":"10.4238\/2012.September.20.3","article-title":"Expression of IL-1\u03b2, IL-6, TNF-\u03b1, and iNOS in pregnant women with periodontal disease","volume":"11","author":"Otenio","year":"2012","journal-title":"Genet Mol Res"},{"key":"10.1016\/j.joms.2020.08.012_bib26","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/nrrheum.2014.127","article-title":"IL-6 biology: Implications for clinical targeting in rheumatic disease","volume":"10","author":"Calabrese","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.joms.2020.08.012_bib27","doi-asserted-by":"crossref","first-page":"eaax5104","DOI":"10.1126\/scitranslmed.aax5104","article-title":"IL-6 blockade reverses bone marrow failure induced by human acute myeloid leukemia","volume":"12","author":"Zhang","year":"2020","journal-title":"Sci Translational Med"},{"key":"10.1016\/j.joms.2020.08.012_bib28","doi-asserted-by":"crossref","first-page":"e1005973","DOI":"10.1371\/journal.ppat.1005973","article-title":"IL-1\u03b2\/IL-6\/CRP and IL-18\/ferritin: Distinct inflammatory Programs in infections","volume":"12","author":"Slaats","year":"2016","journal-title":"PLOS Pathog"},{"key":"10.1016\/j.joms.2020.08.012_bib29","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1084\/jem.20122344","article-title":"Depletion of stromal cells expressing fibroblast activation protein-\u03b1 from skeletal muscle and bone marrow results in cachexia and anemia","volume":"210","author":"Roberts","year":"2013","journal-title":"The J Exp Med"},{"key":"10.1016\/j.joms.2020.08.012_bib30","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00441-012-1546-x","article-title":"Functions of the osteocyte network in the regulation of bone mass","volume":"352","author":"Komori","year":"2013","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.joms.2020.08.012_bib31","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.3390\/ijms20061467","article-title":"Zoledronate Enhances osteocyte-Mediated osteoclast differentiation by IL-6\/RANKL Axis","volume":"20","author":"Kim","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.joms.2020.08.012_bib32","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1742-2094-9-40","article-title":"Blockade of interleukin-6 signaling inhibits the classic pathway and promotes an alternative pathway of macrophage activation after spinal cord injury in mice","volume":"9","author":"Guerrero","year":"2012","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.joms.2020.08.012_bib33","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1074\/jbc.M112.419788","article-title":"Interleukin-6\/Signal transducer and activator of transcription 3 (STAT3) pathway is essential for macrophage infiltration and Myoblast Proliferation during muscle Regeneration","volume":"288","author":"Zhang","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.joms.2020.08.012_bib34","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.bbamcr.2011.01.034","article-title":"The pro- and anti-inflammatory properties of the cytokine interleukin-6","volume":"1813","author":"Scheller J","year":"2011","journal-title":"Biochim Biophys Acta (Bba) - Mol Cell Res"},{"key":"10.1016\/j.joms.2020.08.012_bib35","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1038\/mi.2013.126","article-title":"Neutrophil infiltration favors colitis-associated tumorigenesis by activating the interleukin-1 (IL-1)\/IL-6 axis","volume":"7","author":"Wang","year":"2014","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.joms.2020.08.012_bib36","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3109\/08916934.2012.719950","article-title":"Moonlighting osteoclasts as undertakers of apoptotic cells","volume":"45","author":"Harre","year":"2012","journal-title":"Autoimmunity"},{"key":"10.1016\/j.joms.2020.08.012_bib37","first-page":"36","article-title":"Human neutrophils produce IL-12, IL-10, PGE2 and LTB4 in response to Paracoccidioides brasiliensis","volume":"67","author":"Balderramas","year":"2014","journal-title":"Involvement Tlr2, Mannose Receptor Dectin-1 Cytokine"},{"key":"10.1016\/j.joms.2020.08.012_bib38","doi-asserted-by":"crossref","first-page":"788","DOI":"10.3389\/fendo.2018.00788","article-title":"Interleukin-6 Interweaves the bone marrow Microenvironment, bone loss, and multiple myeloma","volume":"9","author":"Harmer","year":"2019","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.joms.2020.08.012_bib39","doi-asserted-by":"crossref","first-page":"e1004651","DOI":"10.1371\/journal.ppat.1004651","article-title":"Neutrophils: Between Host Defence, immune modulation, and tissue injury","volume":"11","author":"Kruger","year":"2015","journal-title":"PLOS Pathog"},{"key":"10.1016\/j.joms.2020.08.012_bib40","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2217\/bmm-2017-0082","article-title":"Serum TNF-\u03b1, erythrocyte sedimentation rate and IL-6 are more valuable biomarkers for assisted diagnosis of extremity chronic osteomyelitis","volume":"11","author":"Jiang","year":"2017","journal-title":"Biomarkers Med"},{"key":"10.1016\/j.joms.2020.08.012_bib41","first-page":"39","article-title":"Hepatotoxicity of tocilizumab and anakinra in rheumatoid arthritis: Management decisions","volume":"3","author":"Mahamid","year":"2011","journal-title":"Clin Pharmacol Adv Appl"},{"key":"10.1016\/j.joms.2020.08.012_bib42","first-page":"2013","article-title":"Tocilizumab-induced acute liver injury in Adult Onset Still\u2019s disease","volume":"1\u20133","author":"Drepper","year":"2013","journal-title":"Case Rep Hepatol"},{"key":"10.1016\/j.joms.2020.08.012_bib43","doi-asserted-by":"crossref","first-page":"e96053","DOI":"10.1371\/journal.pone.0096053","article-title":"Synthesis of IL-6 by hepatocytes is a normal response to Common hepatic Stimuli","volume":"9","author":"Norris","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.joms.2020.08.012_bib44","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1476-5381.2011.01811.x","article-title":"Concordance of preclinical and clinical pharmacology and toxicology of therapeutic monoclonal antibodies and fusion proteins: Cell surface targets","volume":"166","author":"Bugelski","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.joms.2020.08.012_bib45","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1177\/1933719115612134","article-title":"A humanized anti-interleukin 6 receptor monoclonal antibody, tocilizumab, for the treatment of Endometriosis in a rat model","volume":"23","author":"Taskin","year":"2016","journal-title":"Reprod Sci"},{"key":"10.1016\/j.joms.2020.08.012_bib46","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.cytogfr.2015.07.004","article-title":"Interleukin-6: Biology, signaling and strategies of blockade","volume":"26","author":"Schaper","year":"2015","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.joms.2020.08.012_bib47","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1128\/IAI.69.2.744-750.2001","article-title":"Interleukin-6 Deficiency increases inflammatory bone destruction","volume":"69","author":"Baldo","year":"2001","journal-title":"Infect Immun"}],"container-title":["Journal of Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278239120310570?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278239120310570?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T17:02:44Z","timestamp":1759510964000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278239120310570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":47,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0278239120310570"],"URL":"https:\/\/doi.org\/10.1016\/j.joms.2020.08.012","relation":{},"ISSN":["0278-2391"],"issn-type":[{"type":"print","value":"0278-2391"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tocilizumab, a Potent Interleukin-6 Receptor Inhibitor, Decreases Bone Resorption and Increases the Rate of Bacterial Infection After Tooth Extraction in Rats","name":"articletitle","label":"Article Title"},{"value":"Journal of Oral and Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joms.2020.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Association of Oral and Maxillofacial Surgeons","name":"copyright","label":"Copyright"}]}}